Savient Pharmaceuticals, Inc. (SVNT1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO:
Employees:
ONE TOWER CENTER, EAST BRUNSWICK, NJ 08816
7324189300

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 1.302 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.97
Price to Revenue2.0034 Debt to Equity-1.1425 EBITDA-53.935 Million
Price to Book Value0.0 Operating Margin-347.3325 Enterprise Value246.921 Million
Current Ratio1.978 EPS Growth0.214 Quick Ratio1.73
1 Yr BETA -0.1365 52-week High/Low 0.0 / Profit Margin-430.0595
Operating Cash Flow Growth34.899 Altman Z-Score-18.3411 Free Cash Flow to Firm -61.487 Million
View SEC Filings from SVNT1 instead.

View recent insider trading info

Funds Holding SVNT1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SVNT1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THOMPSON VIRGIL

  • Director
0 2013-12-04 0

JAEGER STEPHEN O

  • Director
0 2013-10-17 0

CONSTANTINE GINGER

  • Director
0 2013-10-16 0

YACHMETZ PHILIP K CO-PRESIDENT AND CBO

  • Officer
90,545 2013-10-15 0

CROWLEY RICHARD CO-PRESIDENT AND COO

  • Officer
171,750 2013-10-15 0

GIONCO DAVID CHIEF ACCOUNTING OFFICER

  • Officer
35,764 2013-10-15 0

BAHRT KENNETH SVP, CHIEF MEDICAL OFFICER

  • Officer
100,000 2013-10-15 0

HAMILL JOHN CO-PRESIDENT AND CFO

  • Officer
66,667 2013-10-15 0

FERRARI LOUIS PRESIDENT AND CEO

  • Officer
  • Director
307,439 2013-05-22 0

VEITCH DAVID PRESIDENT

  • Officer
  • SAVIENT PHARMA IRELAND LIMITED
0 2013-03-05 0

MEEKER DAVID P

  • Director
12,644 2013-01-07 0

SAVAGE ROBERT G.

  • Director
16,149 2012-12-05 0

NORTON DAVID Y

  • Director
69,284 2012-07-09 0

OWEN WILLIAM F

  • Director
56,631 2012-05-22 0

ZUERBLIS KENNETH J EVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2012-02-01 0

JOHNSON JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
252,350 2012-01-03 0

HELLER ALAN L

  • Director
40,179 2011-09-15 0

SIMON LEE S

  • Director
29,179 2011-05-26 0

HAMELIN PAUL PRESIDENT

  • Officer
124,765 2011-02-14 0

KLEIN JOSEPH III

  • Director
17,388 2010-06-08 0

CONRAD HERBERT J

  • Director
28,501 2010-06-08 0

HOROWITZ ZEBULUN D SVP - CHIEF MEDICAL OFFICER

  • Officer
144,683 2009-02-17 0

HAYDEN BRIAN J

  • FORMER CFO
No longer subject to file 2009-02-17 0

LAMM ROBERT

  • FORMER SVP, QA/RA
49,186 2009-02-17 0

CLEMENT CHRISTOPHER G

  • FORMER PRESIDENT & CEO
276,511 2008-12-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments